Literature DB >> 9973041

Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

G A Ewy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9973041     DOI： 10.1016/s0735-1097(98)00596-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

Review 1.  Rational use of inotropic therapy in heart failure.

Authors:  G M Felker; C M O'Connor
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

2.  Chronic inotropic therapy in end-stage heart failure.

Authors:  Paul J Hauptman; Peter Mikolajczak; Anil George; Clinton J Mohr; Robert Hoover; Jason Swindle; Mark A Schnitzler
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

Review 3.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.

Authors:  Paul J Hauptman; Mark A Schnitzler; Jason Swindle; Thomas E Burroughs
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

5.  Acute isoproterenol leads to age-dependent arrhythmogenesis in guinea pigs.

Authors:  Kathleen C Woulfe; Cortney E Wilson; Shane Nau; Sarah Chau; Elisabeth K Phillips; Shulun Zang; Christine Tompkins; Carmen C Sucharov; Shelley D Miyamoto; Brian L Stauffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

Review 6.  End-of-life options for patients with advanced heart failure.

Authors:  Judith Z Goldfinger; Eric D Adler
Journal:  Curr Heart Fail Rep       Date:  2010-09

7.  Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.

Authors:  J H O'Keefe; A Magalski; T L Stevens; D R Bresnahan; K Alaswad; S K Krueger; T M Bateman
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

8.  Clinical, biological, echocardiographic and therapeutic determinants of the length of hospital stay of patients with acute heart failure.

Authors:  A C Nechita; V Enache; A M Stroi; R L Ploesteanu; C Delcea; C S Stamate
Journal:  J Med Life       Date:  2013-12-25

9.  Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers.

Authors:  Luanda Grazette; Jeffrey S Tran; Nadine K Zawadzki; Roy S Zawadzki; Jennifer M McLeod; Michael W Fong; Melissa L Wilson; Ofer Havakuk; Joel W Hay
Journal:  Int J Cardiol Heart Vasc       Date:  2022-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.